InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Janney Daniel, Director. Insider active across 3 companies, notably Esperion Therapeutics, Inc.. Cumulatively, 9 filings have been published. Breakdown: 1 buy · 6 sells. Total volume traded: €17.9m. History available since 27 May 2021. The latest transaction was disclosed on 27 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Janney Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
9,430 shares@ US$275.448714.2% of flowCommon StockSEC:0001711279-26-000023:0
37,895 shares@ US$2.460.5% of flowCommon StockSEC:0001711279-26-000021:0
4,604 shares@ US$127.95782.8% of flowCommon StockSEC:0001711279-23-000046:0
50,000 shares@ US$95.023722.6% of flowCommon StockSEC:0001711279-23-000042:0
17,100 shares@ US$90.73567.3% of flowCommon StockSEC:0001711279-23-000035:0
7,900 shares@ US$90.31563.3% of flowCommon StockSEC:0001711279-23-000023:0
475,000 shares@ US$5.02100.0% of flowCommon StockSEC:0001209191-22-051141:0
Canonical exit: 20 Dec 2022 (T+90)
100,000 shares@ US$70.5040.2% of flowCommon StockSEC:0000899243-21-048122:0
12,376 shares0Common StockSEC:0001628280-21-011356:0
9 of 9 declarations
About Janney Daniel
Daniel Janney serves as a Director at Esperion Therapeutics, Inc. and Krystal Biotech, Inc. In this role, he contributes to the strategy and governance of the companies. His expertise in the biopharmaceutical sector is an asset to the board.
